Verrica Pharmaceuticals (NASDAQ: VRCA)
$5.99
(9.6%)
$0.52
Price as of August 25, 2025, 4:00 p.m. ET
Verrica Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Verrica Pharmaceuticals Company Info
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
News & Analysis
Featured Article
Verrica Posts Profit in Fiscal Q2
Motley Fool Markets Team | Aug 12, 2025
Featured Article
Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday
The company's shares dropped because it will require financing to help launch its first marketed product.
James Halley | Jul 24, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.